Health Ministry to review ban on anti-diabetes drug Pioglitazone

Shalini, CNN-IBN | Jul 19, 2013 at 01:40pm


The Health Ministry is expected to decide on the fate of anti-diabetes drug Pioglitazone on Friday. The verdict is likely to affect millions of users. The drug has been banned in Germany and France because of the side-effects like gallbladder cancer.